• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • Samples
    • MRI Images
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

EPAD trial delivery centres

The EPAD Longitudinal Cohort Study is not longer recruiting and following up participants. We recruited research participants from centres across Europe.

Scotland / Ireland

University of Edinburgh

NHS Tayside, Dundee

NHS Glasgow

NHS Grampian

England / Wales

University of Oxford

WLMHT, London

GM:CRN, Manchester

University of Cambridge

NBT, Bristol

Sheffield

France

CHUT, Toulouse

CHUN, Nantes

CHRU, Lille

Paris Lariboisiere (Paris Nord)

Montpellier

Paris La Salpetriere

Spain / Greece

BBRC, Barcelona

CITA, San Sebastian

Fundacio ACE, Barcelona

Aeginition Hospital Athens

Santander

Hospital Clinic de Barcelona

Benelux

VUmc, Amsterdam

Brussels CUSL

Nordics

KI, Sweden

Gothenburg, Sweden

Switzerland/Italy

HUG, Geneva

IRCCS – Fatebenefratelli, Brescia

Perugia, Italy

Lausanne, Switzerland

 

Share this page
FacebookTwitterLinkedInGoogle+
Latest News
  • Explore the AD Workbench to access the EPAD LCS data
    2021-04-16
  • New paper on the operationalization of the ATN classification scheme in preclinical AD has been published
    2021-04-06
  • AD Workbench
    The final EPAD dataset is now available on the Alzheimer’s Disease Workbench
    2021-03-18
  • EPAD_WordCloud
    EPAD releases its first data and sample access bulletin
    2021-03-10
  • Closing EPAD article published in the Alzheimer Europe magazine
    2021-02-24
View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

Exciting news ☺️👏 Great to hear that the @IMI_AMYPAD Prognostic Study will continue its enrolment and follow up of participants from @IMI_EPAD and other non-EPAD cohorts. The new timings would also facilitate the data integration across all cohorts. twitter.com/IMI_AMYPAD/sta…

reply retweet favorite
7:49 am · 2021-05-05
Twitter
EPAD
EPAD
@IMI_EPAD

The data collected during the @IMI_JU period of @IMI_EPAD from research participants throughout their participation in the Longitudinal Cohort Study are accessible in the @AlzData #ADWorkbench. #DataSharing #OpenAccess ep-ad.org/2021/04/16/exp… twitter.com/AlzData/status…

reply retweet favorite
7:39 am · 2021-05-05
Twitter
EPAD
EPAD
@IMI_EPAD

Are you interested into #neurodegeneration #research? Check out the @IMI2_NEURONET's Knowledge Base to find @IMI_JU project deliverables, tools, publications & assets. 📌18 projects 📚437 publications ✅82 assets 👩‍💻2300 individuals ➡️kb.imi-neuronet.org pic.twitter.com/dTz2EsjEN8

reply retweet favorite
9:16 am · 2021-05-03
Twitter
EPAD
EPAD
@IMI_EPAD

Have a look on the latest edition of the @AlzheimerEurope magazine. The first section includes a closing article on @IMI_EPAD. Our co-leads @craig_ritchie68 and Serge Van der Geyten have been interviewed and reflect on the achievements of the project. ep-ad.org/2021/02/24/5385 pic.twitter.com/Y3jpEVmjCS

reply retweet favorite
7:57 am · 2021-04-26
Twitter
EPAD
EPAD
@IMI_EPAD

The latest and final @IMI_EPAD dataset is available in the @AlzData #ADWorkbench. Explore this data platform infrastructure that streamlines access to #data. Sign up for an account today! ep-ad.org/2021/04/16/exp… pic.twitter.com/1xKWrJIEx2

reply retweet favorite
1:56 pm · 2021-04-22
Copyright © 2015-2021 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.